Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Kratom Country Review
We searched 60,000 characters of its product copy for "withdrawal" and "addict". Neither appears once — on a store selling an opioid-receptor agonist in 1,600-capsule bags.
Kratom Country
No Dependence Warning At AllThe core problem: zero mentions of withdrawal, dependence or addiction across the whole catalogue, and one page offers kratom as “the perfect solution” for “sleepless nights and chronic pain”. The CDC recorded kratom as a cause of death in 91 cases across 27 states, seven with no other substance involved. The FDA linked a 199-case Salmonella outbreak to kratom products and found lead and nickel in others.
Credit where earned: the footer names eleven banned states plus specific cities and twelve countries it will not ship to — genuine diligence. Some products disclose actual mitragynine content (2.0%, 1.5%+), the FAQ admits batch-to-batch alkaloid variation and advises consulting a doctor, and we found no 7-OH products. But the FAQ’s ban list omits five states the footer includes.
For readers of this site there is a specific reason to avoid it: kratom causes nausea, vomiting and constipation — the same effects your GLP-1 causes — and the constipation compounds through a second mechanism. Checked 8 August 2026: powders $6.99-$144, capsules $16-$225 up to 1,600 count, shots to ~$201, gummies $9.99-$168, 30-day guarantee, free shipping over $125.
Affiliate disclosure: GLP1Drugs.org earns 7% if you buy through the links on this page. Our recommendation is not to buy, and we would rather earn nothing here. Verified 8 August 2026.
Visit Kratom CountryOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
0
Mentions Of Withdrawal
91
CDC Deaths Attributed
199
In The Salmonella Outbreak
11
States It Cannot Ship To
What We Verified
Catalogue pulled from the store's own product feed and searched for dependence language; CDC and FDA figures from published sources; restrictions read from the site's footer and FAQ. 8 August 2026.
Zero Mentions Of Withdrawal Or Dependence
We searched roughly 60,000 characters of this store's product copy for 'withdrawal' and 'addict'. Neither appears once. For a substance acting on mu-opioid receptors, that is the most consequential omission on the site
And It Is Offered For Chronic Pain
Verbatim from a product page: "Bring on the sleepless nights and chronic pain, these bad boys might be the perfect solution for your needs." Chronic pain and insomnia are diagnosable conditions and this is an unapproved substance
The CDC Counted 91 Deaths Where Kratom Was A Cause
Across 27 states from July 2016 to December 2017, kratom was detected in 152 unintentional overdose deaths and recorded as a cause of death in 91 of them — including seven where it was the only substance involved
A 2018 Salmonella Outbreak Hospitalised Nearly 40%
The FDA linked a multistate Salmonella outbreak to kratom products, affecting 199 people across 41 states, of whom 38% required hospitalisation. The FDA has separately found high levels of lead and nickel in kratom products
But Its Legal Restrictions Are Genuinely Thorough
The footer names eleven states plus specific cities and counties where it will not ship, and twelve countries. That is more diligence than most vendors of restricted products show
Though The FAQ Under-States That List By Five States
The footer bans Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Rhode Island, Tennessee, Vermont, Utah and Wisconsin. The FAQ lists six of those — omitting Connecticut, Kansas, Louisiana, Tennessee and Utah
Why This Stacks Badly With A GLP-1
Three of kratom's common effects are three of your medication's common effects. One of them compounds through a second mechanism.
| Effect | From Your GLP-1 | From Kratom | Combined |
|---|---|---|---|
| Constipation | Slowed gastric emptying and gut transit | Opioid-receptor slowing of motility | Two brakes on one system |
| Nausea & vomiting | Very common, worst after dose increases | Commonly reported | You cannot tell which caused it |
| Dehydration risk | Reduced appetite usually means reduced fluids | Vomiting adds further losses | Worse than either alone |
| Dependence | — | Documented, with a withdrawal syndrome | Never mentioned on this site |
If constipation is your problem, the answers are fluids, fibre, movement and a conversation about titration pace. Our side-effects guide covers them, and our provider rankings cover prescribers who will adjust your dose rather than leave you to self-medicate.
Pros & Cons
Pros
- ✓The footer publishes a detailed shipping-restriction list: eleven US states plus named cities and counties where kratom is banned
- ✓International prohibitions are also listed, including Australia, Denmark, Finland, Israel, Malaysia, Sweden and Thailand
- ✓"Void Where Prohibited by Law" appears in the footer, placing the legal position in front of buyers
- ✓Mitragynine content is actually disclosed on some products — 2.0% on an enhanced extract and 1.5%+ on a reserve powder
- ✓The FAQ is honest that potency varies: "Each batch is unique due to variations in alkaloid content"
- ✓The FAQ advises consulting a doctor before use, "especially if you are on medication"
- ✓Products are described as made in an FDA-registered, cGMP facility and third-party lab tested for safety and purity
- ✓Lab report and lab testing pages are linked from the footer
- ✓A 30-day money-back guarantee, with a published phone number and order email
- ✓We found no 7-hydroxymitragynine or 7-OH products in the catalogue, which matters given the July 2026 federal scheduling action
- ✓The standard FDA disclaimer is present, stating the products are not intended to diagnose, treat, cure or prevent any disease
- ✓Free shipping over $125, with capsule counts and gram weights stated per product
Cons
- ✕No mention of dependence, withdrawal or addiction anywhere in roughly 60,000 characters of product copy that we searched
- ✕One product page offers kratom as "the perfect solution" for "sleepless nights and chronic pain" — a disease claim for an unapproved substance
- ✕We found no age gate and no 21+ or 18+ statement anywhere in the product copy
- ✕The FAQ's list of banned states omits five that the footer includes, so a buyer in Tennessee or Utah could be misled
- ✕"FDA-registered facility" is easily misread as FDA approval; registration is a filing requirement, not an endorsement
- ✕A combined Kava and Kratom Shot pairs two substances each independently associated with liver injury
- ✕Liquid kratom shots up to $201 and extracts concentrate the alkaloids, which raises overdose and dependence risk relative to leaf powder
- ✕Bulk sizes run to 1,600 capsules and multi-kilogram powders, which is a lot of an opioid-receptor agonist to have in the house
- ✕Kratom causes nausea, vomiting and constipation — the same side effects GLP-1 medicines cause, and the constipation compounds
- ✕The FDA has not approved kratom for any medical use and has advised consumers against using it
- ✕The refund window is stated as 30 days from delivery in the FAQ and 30 days from the order date in the policy
- ✕Commission here is 7%, and we would rather you did not buy at all
Our Verdict
2.2 / 5 — a diligent shipping-restrictions page attached to a catalogue that never once mentions dependence.
We searched this store's entire product catalogue — roughly 60,000 characters of its own copy — for the words "withdrawal", "addict" and "dependence". None of them appears. Kratom's principal alkaloids act at mu-opioid receptors, physical dependence with a documented withdrawal syndrome is among the most consistently reported consequences of regular use, and this retailer sells capsules in bags of up to 1,600 with bulk discounts. A shop selling daily quantities of an opioid-receptor agonist that never tells a first-time buyer it can be habit-forming has omitted the single most important fact about its own product. And on at least one page it goes further in the other direction: "Bring on the sleepless nights and chronic pain, these bad boys might be the perfect solution for your needs." That is a claim to treat two diagnosable conditions with a substance the FDA has not approved for any medical use and has advised consumers against — and it contradicts the site's own footer disclaimer.
The safety record behind that silence is specific rather than vague. The CDC examined unintentional overdose deaths across 27 states between July 2016 and December 2017, found kratom detected in 152 and recorded as a cause of death in 91 — including seven cases where it was the only substance involved, which is the detail that undercuts the usual polydrug defence. The FDA linked a multistate Salmonella outbreak to kratom products in 2018 affecting 199 people across 41 states with 38% hospitalised, and has separately reported finding high levels of lead and nickel in kratom products. Liver injury is documented. Against that background, this catalogue sells a combined Kava and Kratom Shot — pairing two substances each independently associated with hepatotoxicity in one drink — alongside extracts and liquid shots that concentrate the alkaloids and shrink the margin for error relative to leaf powder. We also found no age gate and no 21-plus statement anywhere in the product copy.
It would be unfair not to record what the vendor does well, because parts of it are genuinely better than the category. The footer restriction list is thorough: eleven states named, plus specific cities and counties including San Diego, Oceanside, Sarasota County, Idaho Falls, Jerseyville, Ontario in Oregon and Union County in Mississippi, plus twelve countries. Some products disclose actual mitragynine content — 2.0% on an enhanced extract, 1.5% or more on a reserve powder — which is real potency information and rare here. The FAQ is honest that alkaloid content varies between batches, advises consulting a doctor especially if you take medication, and the FDA disclaimer is present. We found no 7-hydroxymitragynine products, which matters given the federal scheduling action on 7-OH earlier this year. Two flaws in that otherwise good compliance work: the FAQ's banned-state list omits five states the footer includes, so a buyer in Tennessee or Utah could be misled; and "made in an FDA-registered, cGMP facility" reads to most people as federal approval when registration is merely an administrative filing.
For readers of this site there is one more reason, and it is specific. Kratom's common effects include nausea, vomiting and constipation — three of the most common effects of semaglutide and tirzepatide. The constipation compounds through a second mechanism, since opioid-receptor agonism slows motility while your medication is already slowing gastric emptying. Reduced fluid intake plus vomiting is a dehydration problem. And if symptoms appear, neither you nor your prescriber will know which drug to adjust. So our recommendation is not to buy. If you already use kratom, tell your prescriber, never combine it with opioids, benzodiazepines or alcohol, prefer weighed leaf powder over extracts and shots, and know that stopping after regular use can produce withdrawal worth planning with a clinician. If you are using it for pain, get the pain diagnosed. We earn 7% here and would rather earn nothing.
Visit Kratom CountryFrequently Asked Questions
What is the single biggest problem with this site?
That it never mentions dependence, and we checked this specifically rather than assuming. We pulled the store's full product catalogue and searched roughly 60,000 characters of its own descriptions for the words "withdrawal", "addict" and "dependence". Not one appears. Kratom's principal alkaloids act at mu-opioid receptors — that is the mechanism behind both its effects and its risks — and physical dependence with a documented withdrawal syndrome is among the most consistently reported consequences of regular use. People describe irritability, muscle aches, insomnia, sweating, nausea and cravings on stopping. A retailer selling daily-use quantities of an opioid-receptor agonist, in bulk sizes running to 1,600 capsules, that never once tells a customer this can be habit-forming, has omitted the most important thing a first-time buyer needs to know. To be fair about what the site does say: it advises consulting a doctor before use, especially if you are on medication, it is honest that alkaloid content varies between batches, and it carries the standard FDA disclaimer. Those are real. But none of them is a warning about dependence, and the absence is not a small editorial gap — it is the gap that determines whether someone starting today understands what they are starting.
Is it really being sold for chronic pain?
On at least one product page, yes, and in those words. The description for a red vein capsule product reads: "Bring on the sleepless nights and chronic pain, these bad boys might be the perfect solution for your needs." That is a claim to treat two diagnosable conditions — chronic pain and insomnia — made for a substance the FDA has not approved for any medical use and has advised consumers against using. It also sits directly against the site's own footer disclaimer that the products are "not intended to diagnose, treat, cure or prevent any disease", which is the same self-contradiction we have flagged at several brands in this series, but with considerably higher stakes because of what kratom is. Elsewhere the framing is softer — products are organised by "Effect" into Relaxation, Energy and Mood Boost, and bundles are named for those effects rather than conditions. So this is not a catalogue saturated with medical claims. It is a catalogue with a serious one in it. The practical point for a reader: chronic pain deserves diagnosis and a management plan, and self-treating it with an unregulated opioid-receptor agonist risks both the underlying cause going uninvestigated and a dependence problem layered on top of the original pain.
How dangerous is kratom, actually?
Not benign, and the specific numbers are worth having rather than a general sense of unease. On deaths: the CDC examined unintentional overdose deaths across 27 states from July 2016 to December 2017 and found kratom detected in 152 of them, with kratom recorded as a cause of death in 91 — including seven cases where it was the only substance involved. That last detail matters, because the usual defence is that kratom deaths always involve other drugs, and in seven cases they did not. On contamination: the FDA linked a multistate Salmonella outbreak to kratom products in 2018 that affected 199 people across 41 states, of whom 38% were hospitalised, and the FDA has separately reported finding high levels of heavy metals including lead and nickel in kratom products. On liver: hepatotoxicity is a documented risk. The FDA has not approved kratom for any medical use and has advised against consumer use; Mayo Clinic's published position is titled "Kratom: Unsafe and ineffective". None of this makes kratom illegal in most of the United States, and adults make their own choices about legal substances — but anyone buying should know that the safety record includes attributed deaths, a large contamination outbreak and heavy-metal findings, and that this vendor's own copy mentions none of it.
Does it interact with GLP-1 medication?
The side effects stack in a way that is genuinely worth planning around, and this is the specific reason we would advise against it for readers of this site. Kratom's common adverse effects include nausea, vomiting and constipation. Those are also three of the most frequently reported effects of semaglutide and tirzepatide. The constipation in particular compounds rather than merely coexisting: GLP-1 medicines slow gastric emptying and gut transit, and opioid-receptor agonism slows intestinal motility through a different mechanism, so you are applying two brakes to the same system. Severe constipation is not a trivial outcome — it can progress to impaction. There is a second, subtler risk. Appetite and fluid intake are commonly reduced on a GLP-1, so someone already under-hydrated who then experiences kratom-induced vomiting is in a worse position than either problem alone would suggest. And a third: attribution. If you develop persistent nausea and vomiting while taking both, neither you nor your clinician will know which is responsible, which makes the sensible clinical response — adjusting your titration — harder to judge. Kratom is also metabolised via cytochrome P450 enzymes and can interact with other medicines. If you take kratom, tell your prescriber, and never combine it with opioids, benzodiazepines, alcohol or other sedatives.
What about the Kava and Kratom Shot?
That is the product in this catalogue we would avoid most firmly, and the reason is the liver. Kava has a documented association with hepatotoxicity — severe liver injury including cases requiring transplant led several countries to restrict or ban it, and it remains the subject of regulatory caution in many jurisdictions. Kratom is also associated with drug-induced liver injury. Combining two substances that are each independently implicated in hepatotoxicity, in a single ready-to-drink shot, concentrates a risk that neither carries alone to the same degree. On top of that, both are sedating, and the combination compounds sedation in a way that is difficult to titrate from a shot you drink in one go. The liquid format is the other issue. Extracts and shots concentrate the alkaloids relative to leaf powder, which means the dose per swallow is higher and the margin for error smaller — and this catalogue sells liquid kratom shots priced up to around $201 as well as extract softgels and enhanced extracts at 2.0% mitragynine. If someone is determined to use kratom despite everything above, plain leaf powder at a low, weighed dose is a more controllable proposition than an extract shot, and a kava combination is the last thing we would reach for.
Is the legal position handled properly?
Better than we expected, with one inconsistency that could actually catch someone out. The footer is thorough: "Kratom can NOT be shipped or sold to the following states and counties where it is banned: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Rhode Island, Tennessee, Vermont, Utah, and Wisconsin", followed by named municipalities including San Diego and Oceanside in California, Sarasota County in Florida, Idaho Falls, Jerseyville in Illinois, Ontario in Oregon and Union County in Mississippi, plus a note about other local bans in Illinois, Louisiana, Mississippi and New Hampshire. International prohibitions are listed too, covering Australia, Burma, Denmark, Finland, Israel, Lithuania, Malaysia, Poland, Romania, South Korea, Sweden and Thailand. That is genuine diligence and more than several vendors of restricted products manage. The problem is that the FAQ gives a shorter list: "Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, and certain cities/counties" — omitting Connecticut, Kansas, Louisiana, Tennessee and Utah. A buyer in Tennessee or Utah who reads the FAQ, as most people would, could reasonably conclude their state is fine. The footer is the accurate one. Kratom law also changes frequently, so check a current source for your own state rather than either list, and note the vendor's own "Void Where Prohibited by Law" caveat puts that responsibility on you.
How good is the quality control?
The claims are reasonable and one of them is commonly misread, so it is worth separating them. What is genuinely useful: some products disclose actual mitragynine content — 2.0% on an enhanced extract powder and 1.5% or more on a reserve powder — which is real potency information and unusual in this category, where most vendors sell by strain name alone. The FAQ is also candid that "Each batch is unique due to variations in alkaloid content", which is honest about the fundamental problem with a botanical product. Products are described as third-party lab tested for safety and purity with testing said to confirm no additives, heavy metals or biological contaminants, and lab report pages are linked from the footer, though we did not open a specimen certificate and so cannot tell you the panel scope. Now the claim to read carefully: "Made in an FDA-registered, cGMP facility." FDA registration of a facility is an administrative filing requirement for food and supplement manufacturers — it is not an approval, an inspection outcome, or any statement about the product. Given that the FDA's actual position on kratom is to advise against consumer use, describing a kratom product as coming from an FDA-registered facility is technically accurate and easily misunderstood as federal endorsement. We would also note we found no reference to the American Kratom Association's GMP standards programme, which is the industry's own audited certification.
What does it cost, and what are the terms?
Cheap to start and cheap to escalate, which is part of the concern. Observed on 8 August 2026: kratom powders from $6.99 to about $144 depending on quantity, capsules from $16 to roughly $225, gummies from $9.99 to about $168, extract softgels $15.99 to $49.99, liquid kratom shots from $13.99 up to around $201, and a Kava and Kratom Shot from $9.99. Bundles include an Energy Kratom Bundle at $107.97, a Relaxation Kratom Bundle at $108.87, an Enhanced Kratom Sampler at $111.99 and a powder variety bundle at $157.96. Capsules are sold by count up to 1,600 per bag, with each capsule stated to contain about 0.5 grams of powder. Free shipping applies over $125. Terms: a 30-day money-back guarantee, with the FAQ saying to email within 30 days of delivery and the refund policy saying returns are accepted within 30 days of the order date — a small inconsistency, and returns must be authorised first. There is a subscription option with a cancellation policy and a loyalty programme. Our observation on the pricing structure rather than the prices: bulk discounting on a substance that produces tolerance and dependence means the cheapest way to buy is also the way that puts the largest quantity in your house, and that is precisely the wrong incentive for this product category.
So what is your recommendation?
Do not buy it, and we will be straightforward about why rather than hiding behind hedges. Kratom acts on mu-opioid receptors; the CDC attributed 91 deaths to it across 18 months of data in 27 states, seven of those with no other substance involved; the FDA has linked a 199-case Salmonella outbreak to kratom products and found lead and nickel in others; liver injury is documented; and the FDA has advised consumers against using it. This particular vendor never mentions dependence or withdrawal anywhere in its product copy, has no age gate we could find, sells a kava-kratom combination that stacks two hepatotoxic substances, and on at least one page offers the product as a solution for chronic pain. For a reader of this site there is an additional and specific reason: kratom's nausea, vomiting and constipation are the same effects your GLP-1 causes, the constipation compounds through a second mechanism, and if you develop symptoms neither you nor your prescriber will know which drug to blame. If you already use kratom, tell your prescriber, never combine it with opioids or sedatives, avoid extracts and shots in favour of weighed leaf powder at a low dose, and know that stopping after regular use can produce withdrawal — which is worth planning with a clinician rather than alone. If you are using it for pain, that pain deserves a diagnosis. We earn 7% here and would rather earn nothing.
If You Are Using It For Pain, Get The Pain Diagnosed.
An opioid-receptor agonist sold in 1,600-capsule bags, with no mention of dependence anywhere on the site — and whose nausea, vomiting and constipation stack with your medication's.
Visit Kratom CountryCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →Amazon One Medical
Brand-Name, No CompoundingFDA-approved Wegovy, Zepbound and Foundayo from $149/month cash, $25 with insurance and $50/month for eligible Medicare members — the first mainstream route to approved medication at prices that compete with compounded. We earn no commission from it
Read Review →LifeMD
Top RatedPublicly traded telehealth company with comprehensive health platform and competitive pricing
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →Alan Meds
Top RatedAffordable compounded GLP-1s with board-certified physicians and straightforward pricing
Read Review →Medical & Safety Disclaimer: This page is informational and is not medical advice. Kratom (Mitragyna speciosa) is not approved by the FDA for any medical use, and the FDA has advised consumers not to use it; it is not a dietary supplement, not a medicine, and is not intended to diagnose, treat, cure or prevent any disease. Its principal alkaloids act at mu-opioid receptors. Regular use can cause physical dependence and a withdrawal syndrome, and kratom use disorder is described in the clinical literature; do not stop abruptly after heavy or prolonged use without clinical advice. Reported harms include nausea, vomiting, constipation, dizziness, sedation, tachycardia, seizures, drug-induced liver injury, respiratory depression and death. The CDC identified kratom in 152 unintentional overdose deaths across 27 states between July 2016 and December 2017 and recorded it as a cause of death in 91, including seven in which no other substance was involved. The FDA linked a 2018 multistate Salmonella outbreak affecting 199 people to kratom products, and has reported finding high levels of heavy metals including lead and nickel in kratom products. Never combine kratom with opioids, benzodiazepines, alcohol, other sedatives, or monoamine oxidase inhibitors; fatal interactions have been reported. Kratom is metabolised by cytochrome P450 enzymes and can interact with many prescription medicines — disclose any kratom use to your prescriber and pharmacist. Do not use if pregnant, trying to conceive, or breastfeeding; neonatal withdrawal has been reported. Do not drive or operate machinery after use. Kava is independently associated with severe liver injury and combining it with kratom compounds hepatotoxic risk. Extracts and concentrated shots deliver substantially higher alkaloid doses than leaf powder and carry correspondingly greater risk. Kratom's legality varies by state, county and city and changes frequently; verify your local law from a current authoritative source before ordering, as compliance is your responsibility. Chronic pain, insomnia and low mood require clinical assessment; self-treating them with an unregulated substance risks leaving the underlying cause uninvestigated. If you or someone else may have overdosed, contact emergency services or a poison control centre immediately. For substance use concerns in the US, the SAMHSA National Helpline is 1-800-662-4357. GLP-1 medicines delay gastric emptying and their gastrointestinal effects overlap with kratom's. Consult a licensed clinician before starting or changing any treatment.
Date reviewed: 8 August 2026. The catalogue was retrieved from kratomcountry.com's public product feed on that date and may change; 40 product listings were returned. Prices observed: Green and White Maeng Da Kratom Powder from $6.99, Red Bali and Red Thai Kratom Powder from $7.49, Red Maeng Da and Vietnam Kratom Powder from $9.49, blueberry, mango and strawberry Kratom Gummies from $9.99, Kava and Kratom Shot from $9.99, Liquid Kratom Shot from $13.99, Kratom Extract Soft Gels $15.99 to $49.99, and kratom capsules from $16.00, with top-of-range variant prices reaching approximately $144 for powders, $225 for capsules, $168 for gummies and $201 for shots; bundles included an Energy Kratom Bundle at $107.97, a Relaxation Kratom Bundle at $108.87, a Berry Burst Kratom Gummies Bundle and Enhanced Kratom Sampler at $111.99, a Kratom Powder Strain Variety Bundle at $157.96 and a Super Kratom Gummies Bundle at $167.99. Free shipping was advertised on orders over $125. We searched the combined product titles and descriptions, approximately 60,398 characters, for the terms 'withdrawal', 'addict', '7-hydroxy', '7-OH', '7OH', '21+', '18+' and 'American Kratom'; none returned any occurrence. 'Depend' occurred once, in the phrase 'depending on your needs and timing', not in the sense of dependence. Quoted product copy is the vendor's own: 'Bring on the sleepless nights and chronic pain, these bad boys might be the perfect solution for your needs'; 'Made in an FDA-registered, cGMP facility'; 'Third-party lab-tested for safety and purity'; '30-day satisfaction guarantee – if you're not satisfied, you'll get a full refund'; 'We have a rigorous testing process that confirms that our leaves are properly sourced, that there are no additives, heavy metals, biological contaminants'; '2.0% mitragynine' on an enhanced extract and 'high MIT profile at 1.5%+ mitragynine' on a reserve powder; capsules stated to contain 'about 0.5 grams of kratom powder' and available in counts up to 1,600; and the footer disclaimer 'These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease' together with advice to seek a doctor's advice 'if you have a medical condition or use prescription medications'. The footer states: 'Void Where Prohibited by Law. Kratom can NOT be shipped or sold to the following states and counties where it is banned: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Rhode Island, Tennessee, Vermont, Utah, and Wisconsin', followed by named municipalities including San Diego, CA; Oceanside, CA; Sarasota County, FL; Idaho Falls, ID; Jerseyville, IL; Ontario, OR; and Union County, MS, plus other municipalities in Illinois, Louisiana, Mississippi and New Hampshire, and prohibited countries including Australia, Burma (Myanmar), Denmark, Finland, Israel, Lithuania, Malaysia, Poland, Romania, South Korea, Sweden and Thailand. The FAQ states a shorter list: 'We do not ship to the following locations where kratom is banned: Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, and certain cities/counties' — omitting Connecticut, Kansas, Louisiana, Tennessee and Utah relative to the footer. The FAQ also states 'Each batch is unique due to variations in alkaloid content' and 'We always recommend consulting a doctor before taking kratom, especially if you are on medication'. On returns, the FAQ states a '30-day guarantee' requiring email 'within 30 days of delivery' while the refund policy states 'Returns will be accepted within 30 days of the original date the order was placed' and must be authorised in advance. Lab report and lab testing pages are linked from the footer; we did not open a specimen certificate and make no claim about analytical panel scope. A published telephone number of (877) 300-4668 was listed. CDC and FDA figures are as published: kratom detected in 152 unintentional overdose deaths across 27 states from July 2016 to December 2017 with kratom recorded as a cause of death in 91, including seven sole-substance cases; a 2018 multistate Salmonella outbreak linked to kratom products affecting 199 people across 41 states with 38% hospitalised; and FDA findings of high levels of heavy metals including lead and nickel in kratom products. Mayo Clinic publishes guidance titled 'Kratom: Unsafe and ineffective'. A temporary federal scheduling action concerning 7-hydroxymitragynine above a threshold was published in the Federal Register on 6 July 2026. Katalys offer #317 lists 7.00% default commission.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This programme pays 7% of order value. This does not influence our editorial content or review ratings — our recommendation here is that readers on GLP-1 treatment do not buy these products.